Search results for: Patricia Cubi-Molla
Filter search results
HTA and Appropriate Drug Pricing Worldwide
9 September 2011
…lead article with Prof Patricia Danzon from the Wharton School and Dr Andrew Mulcahy of RAND. The August 2011 issue of Health Affairs featured four articles on how and why…
Age and Utilities: Issues for HTA
1 April 2017
…from: https://link.springer.com/article/10.1007/s11136-018-2071-5 Please cite as: Cubí-Mollá, P., Shah, K., Garside, J., Herdman, M. and Devlin, N., 2018. A Note on the Relationship Between Age and Health-related Quality of Life. Quality…
Why Do Immigrants Report Lower Life Satisfaction?
1 July 2017
…is decreasing. A new OHE Research paper by Cubi-Molla and Yaman (2017) explores changes in the reporting behaviour of immigrants in Germany 1984-2010, in questions related to life satisfaction. Previous…
A Study of the Relationship Between Health and Subjective Well-being in Parkinson’s Disease Patients
1 July 2013
…Value in Health and can be downloaded from: https://www.sciencedirect.com/science/article/pii/S1098301514000539 Please cite as: Cubí-Mollá, P., De Vries, J. and Devlin, N., 2014. A study of the relationship between health and subjective…
Resource Allocation in Public Sector Programmes: Does the Value of a Life Differ Between Governmental Departments?
1 February 2021
…threshold: a bargaining approach. OHE Consulting Report, London: Office of Health Economics. Available at: https://www.ohe.org/publications/bargaining-approach-theory-icer-pricing-and-optimal-level-cost-effectiveness-threshold Cubi-Molla, P., Mott, D., Henderson, N. et al. Resource allocation in public sector programmes: does…
It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?
1 December 2021
…Research Paper, London: Office of Health Economics. Available at: https://www.ohe.org/publications/ittakestwototango:whendoconditionsinwhichrisksharingschemes improve value formoney Related Research Cole, A., Cubi-Molla, P., Elliott, R., Feast, A., Hocking, L., Lorgelly, P., Payne, K., Peek,…
Setting the Right Discount Rate for HTA in the Slovak Republic
21 May 2023
…containing the full set of recommendations and details of our analysis, click here. Citations Hitch J., Berdud M., Cubi-Molla P., Garau M., Towse A., 2023. Setting the right discount rate…
Rare Disease Day 2024: Why Do We Care About Rare?
29 February 2024
…in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases – OHE. Office of Health Economics. Published January 9, 2021. Accessed February 27, 2024. https://www.ohe.org/publications/case-study-analysis-challenges-nice-evaluation-multi-indication-medicines-rare-and/ Cole A, Cubi-Molla…
Kahneman’s legacy in health economics
4 April 2024
…Y. (2022). Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L. PharmacoEconomics, 40(Suppl 2), 139–146. Skedgel, C., Cubi-Molla, P., Mott, D., Gameiro, S., Boivin, J., Al-Janabi,…